< Back to scientific publications

Magazine 9.54

Brivaracetam as add-on treatment in patients with post-stroke epilepsy: real-world data from the BRIVAracetam add-on First ItalianųoRk Study (BRIVAFIRST).

Authors: Lattanzi S, Canafoglia L, Canevini MP, Casciato S, Irelli EC, Chiesa V, Dainese F, De Maria G, Didato G, Gennaro GD, Falcicchio G, Fanella M, Ferlazzo E, Gangitano M, La Neve A, Mecarelli O, Montalenti E, Morano A, Piazza F, Pizzanelli C, Pulitano P, Ranzato F, Rosati E, Tassi L, Di Bonaventura C; BRIVAFIRST Group Membership

Date: 2022

Scope of interest: Epilepsy




You may also be interested in:

Magazine 7

Factors that affect efficacy of ultrasound surveillance for early stage hepatocellular carcinoma in patients with cirrhosis.

Authors: Del Poggio p

Date: 14 Nov 2023

Scope of interest: hepatological


Read details
Magazine 5.44

Pharmacology of new and developing intravenous therapies for the management of seizures and epilepsy.

Authors: Morano A, Iannone L, Palleria C, Fanella M, Giallonardo AT, De Sarro G, Russo E, Di Bonaventura C.

Date: 2018

Scope of interest: Epilepsy


Read details
Report/Poster of Convention/Congress Act

Outpatient Management of Secondary Epistaxis Anemia in Patients with Rendu-Osler Disease: The Role of Intravenous Martial Therapy

Authors: Trimboli M. et. al. D’Amico C. et al.

Date: 2022

Scope of interest: Transfusion Medicine


Read details